Abstract:Transforming growth factor beta (TGF beta) induces hepatic stellate cell (HSC) differentiation into tumor-promoting myofibroblast, although underlying mechanism remains incompletely understood. Focal adhesion kinase (FAK) is activated in response to TGF beta stimulation, so it transmits TGF beta stimulus to extracellular signal-regulated kinase and P38 mitogen-activated protein kinase signaling. However, it is unknown whether FAK can, in return, modulate TGF beta receptors. In this study, we tested whether FAK phosphorylated TGF beta receptor 2 (TGF beta R2) and regulated TGF beta R2 intracellular trafficking in HSCs. The FAKY397F mutant and PF-573,228 were used to inhibit the kinase activity of FAK, the TGF beta R2 protein level was quantitated by immunoblotting, and HSC differentiation into myofibroblast was assessed by expression of HSC activation markers, alpha-smooth muscle actin, fibronectin, or connective tissue growth factor. We found that targeting FAK kinase activity suppressed the TGF beta R2 protein level, TGF beta 1-induced mothers against decapentaplegic homolog phosphorylation, and myofibroblastic activation of HSCs. At the molecular and cellular level, active FAK (phosphorylated FAK at tyrosine 397) bound to TGF beta R2 and kept TGF beta R2 at the peripheral plasma membrane of HSCs, and it induced TGF beta R2 phosphorylation at tyrosine 336. In contrast, targeting FAK or mutating Y336 to F on TGF beta R2 led to lysosomal sorting and degradation of TGF beta R2. Using RNA sequencing, we identified that the transcripts of 764 TGF beta target genes were influenced by FAK inhibition, and that through FAK, TGF beta 1 stimulated HSCs to produce a panel of tumor-promoting factors, including extracellular matrix remodeling proteins, growth factors and cytokines, and immune checkpoint molecule PD-L1. Functionally, targeting FAK inhibited tumor-promoting effects of HSCs in vitro and in a tumor implantation mouse model. Conclusion: FAK targets TGF beta R2 to the plasma membrane and protects TGF beta R2 from lysosome-mediated degradation, thereby promoting TGF beta-mediated HSC activation. FAK is a target for suppressing HSC activation and the hepatic tumor microenvironment.

Up‐regulation of FUT8 Inhibits TGF-β1-induced Activation of Hepatic Stellate Cells During Liver Fibrogenesis

Focal Adhesion Kinase Regulates Hepatic Stellate Cell Activation and Liver Fibrosis.

Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice

Autocrine CTHRC1 activates hepatic stellate cells and promotes liver fibrosis by activating TGF-β signaling

Endothelial POFUT1 controls injury-induced liver fibrosis by repressing fibrinogen synthesis

Site-specific glycoproteomic analysis revealing increased core-fucosylation on FOLR1 enhances folate uptake capacity of HCC cells to promote EMT

Inhibition of TGF-|[beta]|1-receptor posttranslational core fucosylation attenuates rat renal interstitial fibrosis

Single‐Cell Transcriptomic Analysis Reveals a Hepatic Stellate Cell–Activation Roadmap and Myofibroblast Origin During Liver Fibrosis in Mice

Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy.

Upregulation of GLT25D1 in Hepatic Stellate Cells Promotes Liver Fibrosis Via the TGF-β1/SMAD3 Pathway in Vivo and in Vitro

TGF-β1/Smad3 upregulates UCA1 to promote liver fibrosis through DKK1 and miR18a

Regulatory T cells (Tregs) in liver fibrosis

TET1 inhibits liver fibrosis by blocking hepatic stellate cell activation

Fibroblast growth factor 18 attenuates liver fibrosis and HSCs activation via the SMO-LATS1-YAP pathway

FTO-mediated m6A demethylation of ULK1 mRNA promotes autophagy and activation of hepatic stellate cells in liver fibrosis

LncRNA Meg8 Suppresses Activation of Hepatic Stellate Cells and Epithelial-Mesenchymal Transition of Hepatocytes Via the Notch Pathway

Fibroblast growth factor 18 stimulates the proliferation of hepatic stellate cells, thereby inducing liver fibrosis

Embryonic Liver Fodrin Involved in Hepatic Stellate Cell Activation and Formation of Regenerative Nodule in Liver Cirrhosis

H19/miR‐148a/USP4 Axis Facilitates Liver Fibrosis by Enhancing TGF‐β Signaling in Both Hepatic Stellate Cells and Hepatocytes

Mechanisms of Pulmonary Fibrosis Induced by Core Fucosylation in Pericytes

Focal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFβ Receptor 2.